Quidel (NASDAQ:QDEL) is set to post its quarterly earnings results after the market closes on Wednesday, February 21st. Analysts expect Quidel to post earnings of $0.20 per share for the quarter.
Shares of Quidel (NASDAQ QDEL) opened at $44.31 on Wednesday. The company has a market cap of $1,510.00, a PE ratio of -276.94, a price-to-earnings-growth ratio of 1.39 and a beta of 1.02. The company has a quick ratio of 5.68, a current ratio of 6.28 and a debt-to-equity ratio of 0.70. Quidel has a 1-year low of $19.97 and a 1-year high of $49.47.
A number of analysts have commented on the stock. Piper Jaffray Companies reiterated a “buy” rating and issued a $60.00 price objective on shares of Quidel in a report on Wednesday, January 24th. BidaskClub downgraded shares of Quidel from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Canaccord Genuity reiterated a “buy” rating and issued a $48.00 price objective on shares of Quidel in a report on Wednesday, October 25th. Barclays increased their price objective on shares of Quidel from $45.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, November 2nd. Finally, Zacks Investment Research downgraded shares of Quidel from a “hold” rating to a “strong sell” rating in a report on Thursday, December 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company. Quidel presently has an average rating of “Buy” and a consensus price target of $53.50.
ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/14/quidel-qdel-scheduled-to-post-earnings-on-wednesday.html.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.